Evaluation of <i>In-vitro</i> Activity of Ceftazidime-avibactam Against Carbapenem-resistant Gram-negative Bacteria: A Cross-sectional Study from Pakistan
Escalating antimicrobial resistance is a global threat, emphasizing the need to explore alternative treatment options. Hence, we aimed to explore the in-vitro activity of ceftazidime-avibactam (CAZ-AVI) in clinical isolates of carbapenem-resistant gram-negative bacteria.
Authors
- Fareeha Adnan
- Nazia Khursheed (ORCID: https://orcid.org/0009-0006-8227-3396)
- Moiz Ahmed Khan (ORCID: https://orcid.org/0009-0004-2726-277X)
- Momina Ahsan
Publication Details
- Journal
- Journal of Exploratory Research in Pharmacology
- Published
- 2025-03-25
- DOI
- https://doi.org/10.14218/jerp.2025.00001
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00